Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Relationships among antigen presentation, cytokines, immune deviation, and autoimmune disease.

Literature DB >> 7543132

Relationships among antigen presentation, cytokines, immune deviation, and autoimmune disease.

F D Finkelman¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1995 PMID： 7543132 PMCID： PMC2192119 DOI： 10.1084/jem.182.2.279

Source DB: PubMed Journal: J Exp Med ISSN： 0022-1007 Impact factor: 14.307

× No keyword cloud information.

41 in total

1. A common precursor for CD4+ T cells producing IL-2 or IL-4.

Authors: M Röcken; J H Saurat; C Hauser
Journal: J Immunol Date: 1992-02-15 Impact factor: 5.422

2. Effects of in vivo administration of interferon (IFN)-gamma, anti-IFN-gamma, or anti-interleukin-4 monoclonal antibodies in chronic autoimmune graft-versus-host disease.

Authors: S P Umland; S Razac; D K Nahrebne; B W Seymour
Journal: Clin Immunol Immunopathol Date: 1992-04

3. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression.

Authors: L Ding; P S Linsley; L Y Huang; R N Germain; E M Shevach
Journal: J Immunol Date: 1993-08-01 Impact factor: 5.422

4. Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism.

Authors: M Barral-Netto; A Barral; C E Brownell; Y A Skeiky; L R Ellingsworth; D R Twardzik; S G Reed
Journal: Science Date: 1992-07-24 Impact factor: 47.728

5. Aerosolized antigen exposure without adjuvant causes increased IgE production and increased airway responsiveness in the mouse.

Authors: H Renz; H R Smith; J E Henson; B S Ray; C G Irvin; E W Gelfand
Journal: J Allergy Clin Immunol Date: 1992-06 Impact factor: 10.793

6. Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist.

Authors: C S Tripp; S F Wolf; E R Unanue
Journal: Proc Natl Acad Sci U S A Date: 1993-04-15 Impact factor: 11.205

7. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.

Authors: C S Hsieh; S E Macatonia; C S Tripp; S F Wolf; A O'Garra; K M Murphy
Journal: Science Date: 1993-04-23 Impact factor: 47.728

8. The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice.

Authors: R A Seder; W E Paul; M M Davis; B Fazekas de St Groth
Journal: J Exp Med Date: 1992-10-01 Impact factor: 14.307

9. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice.

Authors: M J Rapoport; A Jaramillo; D Zipris; A H Lazarus; D V Serreze; E H Leiter; P Cyopick; J S Danska; T L Delovitch
Journal: J Exp Med Date: 1993-07-01 Impact factor: 14.307

10. Targeting autoantigen to B cells prevents the induction of a cell-mediated autoimmune disease in rats.

Authors: M J Day; A G Tse; M Puklavec; S J Simmonds; D W Mason
Journal: J Exp Med Date: 1992-03-01 Impact factor: 14.307

12 in total

1. Experimental hypersensitivity pneumonitis: influence of Th2 bias.

Authors: M Schuyler; K Gott; V Mapel; A Cherne; K J Nikula
Journal: Int J Exp Pathol Date: 1999-12 Impact factor: 1.925

2. Vaccination with a multi-epitopic recombinant allergen induces specific immune deviation via T-cell anergy.

Authors: Y Cao; M Yang; Z Luo; S S Mohapatra
Journal: Immunology Date: 1997-01 Impact factor: 7.397

3. Th1/Th2 cytokine responses following HIV-1 immunization in seronegative volunteers. The AIDS Vaccine Evaluation Group.

Authors: T G Evans; T Fitzgerald; D C Gibbons; M C Keefer; H Soucier
Journal: Clin Exp Immunol Date: 1998-02 Impact factor: 4.330

Relationships among antigen presentation, cytokines, immune deviation, and autoimmune disease.

1. A common precursor for CD4+ T cells producing IL-2 or IL-4.

2. Effects of in vivo administration of interferon (IFN)-gamma, anti-IFN-gamma, or anti-interleukin-4 monoclonal antibodies in chronic autoimmune graft-versus-host disease.

3. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression.

4. Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism.

5. Aerosolized antigen exposure without adjuvant causes increased IgE production and increased airway responsiveness in the mouse.

6. Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist.

7. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.

8. The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice.

9. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice.

10. Targeting autoantigen to B cells prevents the induction of a cell-mediated autoimmune disease in rats.

1. Experimental hypersensitivity pneumonitis: influence of Th2 bias.

2. Vaccination with a multi-epitopic recombinant allergen induces specific immune deviation via T-cell anergy.

3. Th1/Th2 cytokine responses following HIV-1 immunization in seronegative volunteers. The AIDS Vaccine Evaluation Group.

4. Immunoglobulin response to intrapulmonary immunization of asthmatics.

5. A recombinant BCG vaccine generates a Th1-like response and inhibits IgE synthesis in BALB/c mice.

6. Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis.

7. Tissue cytokine patterns distinguish variants of rheumatoid synovitis.

8. PARP-1 deficiency increases the severity of disease in a mouse model of multiple sclerosis.

9. Heterogeneity of rheumatoid arthritis: from phenotypes to genotypes.

10. Is IL12 necessary in experimental hypersensitivity pneumonitis?